These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 26329338

  • 41. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T, Ishiguro N, Yasuda Y, Ito T, Nangaku M, Iwata H, Kurokawa K.
    Biochem Biophys Res Commun; 1998 Mar 06; 244(1):45-9. PubMed ID: 9514872
    [Abstract] [Full Text] [Related]

  • 42. Prevalence of anti-3-nitrotyrosine antibodies in the joint synovial fluid of patients with rheumatoid arthritis, osteoarthritis and systemic lupus erythematosus.
    Khan F, Siddiqui AA.
    Clin Chim Acta; 2006 Aug 06; 370(1-2):100-7. PubMed ID: 16513103
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Synovial lymphoid neogenetic factors in Behçet's synovitis: do they play a role in self-limiting and subacute course of arthritis?
    Pay S, Musabak U, Simsek I, Erdem H, Pekel A, Sengul A, Dinc A.
    Clin Exp Rheumatol; 2007 Aug 06; 25(4 Suppl 45):S21-6. PubMed ID: 17949547
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors.
    Kokebie R, Aggarwal R, Lidder S, Hakimiyan AA, Rueger DC, Block JA, Chubinskaya S.
    Arthritis Res Ther; 2011 Mar 24; 13(2):R50. PubMed ID: 21435227
    [Abstract] [Full Text] [Related]

  • 48. Identification of autoantibodies against PsoP27 in synovial fluid derived from psoriatic arthritis and rheumatoid arthritis patients.
    Slobodkin M, Polachek A, Furer V, Elkayam O, Gertel S.
    Scand J Clin Lab Invest; 2024 May 24; 84(3):211-217. PubMed ID: 38767606
    [Abstract] [Full Text] [Related]

  • 49. Levels of chemerin and interleukin 8 in the synovial fluid of patients with inflammatory arthritides and osteoarthritis.
    Valcamonica E, Chighizola CB, Comi D, De Lucia O, Pisoni L, Murgo A, Salvi V, Sozzani S, Meroni PL.
    Clin Exp Rheumatol; 2014 May 24; 32(2):243-50. PubMed ID: 24529071
    [Abstract] [Full Text] [Related]

  • 50. Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity.
    Stankovic A, Slavic V, Stamenkovic B, Kamenov B, Bojanovic M, Mitrovic DR.
    Bratisl Lek Listy; 2009 May 24; 110(10):641-6. PubMed ID: 20017457
    [Abstract] [Full Text] [Related]

  • 51. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
    Keenan RT, Swearingen CJ, Yazici Y.
    Clin Exp Rheumatol; 2008 May 24; 26(5):814-9. PubMed ID: 19032813
    [Abstract] [Full Text] [Related]

  • 52. Clinical usefulness of basic fibroblast growth factor and E-selectin in patients with rheumatoid arthritis.
    Sharaki OA, El-Guiziry DA, Abou-Zeid AA, El-Noueam KI, Helal AE, Gaballah AE.
    Egypt J Immunol; 2004 May 24; 11(2):91-100. PubMed ID: 16734121
    [Abstract] [Full Text] [Related]

  • 53. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis.
    Senolt L, Pavelka K, Housa D, Haluzík M.
    Cytokine; 2006 Sep 24; 35(5-6):247-52. PubMed ID: 17079158
    [Abstract] [Full Text] [Related]

  • 54. Resistin in inflammatory and degenerative rheumatologic diseases. Relationship between resistin and rheumatoid arthritis disease progression.
    Fadda SM, Gamal SM, Elsaid NY, Mohy AM.
    Z Rheumatol; 2013 Aug 24; 72(6):594-600. PubMed ID: 23471526
    [Abstract] [Full Text] [Related]

  • 55. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis.
    Liao H, Wu J, Kuhn E, Chin W, Chang B, Jones MD, O'Neil S, Clauser KR, Karl J, Hasler F, Roubenoff R, Zolg W, Guild BC.
    Arthritis Rheum; 2004 Dec 24; 50(12):3792-803. PubMed ID: 15593230
    [Abstract] [Full Text] [Related]

  • 56. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis.
    Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY.
    Clin Exp Rheumatol; 2001 Dec 24; 19(3):321-4. PubMed ID: 11407088
    [Abstract] [Full Text] [Related]

  • 57. Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis.
    Yukioka K, Wakitani S, Yukioka M, Furumitsu Y, Shichikawa K, Ochi T, Goto H, Matsui-Yuasa I, Otani S, Nishizawa Y.
    J Rheumatol; 1992 May 24; 19(5):689-92. PubMed ID: 1613696
    [Abstract] [Full Text] [Related]

  • 58. A lipidomic study of phospholipid classes and species in human synovial fluid.
    Kosinska MK, Liebisch G, Lochnit G, Wilhelm J, Klein H, Kaesser U, Lasczkowski G, Rickert M, Schmitz G, Steinmeyer J.
    Arthritis Rheum; 2013 Sep 24; 65(9):2323-33. PubMed ID: 23784884
    [Abstract] [Full Text] [Related]

  • 59. Nitric oxide synthase is expressed in the lymphomononuclear cells of synovial fluid in patients with rheumatoid arthritis.
    Borderie D, Hilliquin P, Hernvann A, Kahan A, Menkes CJ, Ekindjian OG.
    J Rheumatol; 1999 Oct 24; 26(10):2083-8. PubMed ID: 10529121
    [Abstract] [Full Text] [Related]

  • 60. Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies.
    Weitoft T, Larsson A, Saxne T, Manivel VA, Lysholm J, Knight A, Rönnelid J.
    Scand J Rheumatol; 2017 Sep 24; 46(5):346-352. PubMed ID: 27973973
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.